RxDoctor Payments Data

Clark Rosen, MD

Otolaryngology · San Francisco, CANPI 1609841048

Payments from drug & device makers

$22,788in general payments, 2019–2025

Across 47 payments — averaging $484.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Precigen, Inc.$10K
  • Olympus America Inc.$5K
  • Medtronic$4K
  • Merck$2K
  • Olympus Corporation$2K
  • Steris Corporation$61
  • plus $18 from 1 others

What the payments were for

  • Consulting fees$13,94061%
  • Speaking & faculty fees$2,91013%
  • Travel & lodging$5,32623%
  • Food & beverage$5933%
  • Education$200%

General payments by program year

19
20
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Precigen, Inc.9$9,812
Olympus America Inc.21$5,112
Medtronic(2 entities)6$3,929
Merck2$2,200
Olympus Corporation5$1,658
Steris Corporation1$61
Bolder Surgical LLC3$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$22,788 in reported general payments places this provider in the 90th percentile of 1,021 otolaryngology providers in California.

See all otolaryngology providers in California

Medicare billing

Part B allowed, 2024
$137,795
Medicare patients
275
Services billed
948

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Omeprazole68$972
Ipratropium Bromide14$519
Famotidine49$342

Paid to pharmacies, not to this prescriber.

Other otolaryngology in San Francisco

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →